Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC
November 26, 2014 at 13:33 PM EST
WASHINGTON, Nov 26 (Reuters) - Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Commission said on Wednesday.
